EpiVax is a privately-held biotechnology company based in Providence, RI that is dedicated to the development and implementation of computational immunology tools to benefit the biotechnology industry.
Location: United States, Rhode Island, Olneyville
Employees: 11-50
Phone: +1 401-272-2123
Total raised: $600K
Founded date: 1998
Investors 1
| Date | Name | Website |
| - | AJI Capita... | ajicap.com |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 14.09.2016 | Grant | $600K | - |
Mentions in press and media 22
| Date | Title | Description | Source |
| 01.04.2024 | Novel Immunogenicity Risk Assessment Platform, ISPRI, Facili... | PROVIDENCE, R.I., April 1, 2024 /PRNewswire/ -- In the pursuit of developing novel biologic entities... | en.prnasia... |
| 11.08.2023 | Streamlining Generic Drug Immunogenicity Evaluation: EpiVax'... | PROVIDENCE, R.I., Aug. 11, 2023 /PRNewswire/ -- EpiVax Inc. announces the publication of results fro... | en.prnasia... |
| 17.05.2023 | Providence-based "Biotech start up" EpiVax Celebra... | PROVIDENCE, R.I., May 17, 2023 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") is celebrating its ... | en.prnasia... |
| 10.01.2023 | EpiVax and Zoetis to Collaborate on Swine T cell Epitope Pre... | PROVIDENCE, R.I., Jan. 10, 2023 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") and Zoetis, are pl... | en.prnasia... |
| 31.10.2022 | EpiVax Joins Intravacc, CEPI on Project to Develop Universal... | PROVIDENCE, R.I., Oct. 31, 2022 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") is pleased to anno... | en.prnasia... |
| 13.09.2022 | EpiVax Secures Additional Funding from FDA for Immunogenicit... | PROVIDENCE, R.I., Sept. 13, 2022 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") is pleased to ann... | en.prnasia... |
| 11.06.2022 | EpiVax Poxvirus Vaccine Candidate Predicted to be Effective ... | PROVIDENCE, R.I., June 11, 2022 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") announces that it ... | en.prnasia... |
| 01.12.2021 | EpiVax Progresses on a Vaccine to Address SARS-CoV-2 Variant... | PROVIDENCE, R.I., Dec. 1, 2021 /PRNewswire/ -- Today EpiVax, Inc. ("EpiVax") confirmed tha... | en.prnasia... |
| 04.11.2021 | EpiVax licenses Tregitope Technology to Maruho Co., Ltd. for... | PROVIDENCE, R.I., Nov. 4, 2021 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") is pleased to annou... | en.prnasia... |
| 07.07.2021 | Immunogenicity Expert and FDA Alum Dr. Amy Rosenberg Joins E... | PROVIDENCE, R.I., July 7, 2021 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") is pleased to annou... | en.prnasia... |
Show more